Endogenous antibody response to SARS-CoV-2 in patients who received monoclonal antibodies against COVID-19: A systematic review

Passive immunization with mAbs has been employed in COVID-19. We performed a systematic review of the literature assessing the endogenous humoral immune response against SARS-CoV-2 in patients treated with mAbs. Administration of mAbs in seronegative patients led to a reduction in both antibody titr...

Descripción completa

Detalles Bibliográficos
Autores principales: Lombardi, Andrea, Azzarà, Cecilia, Renisi, Giulia, Viero, Giulia, Gori, Andrea, Bandera, Alessandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Inc. 2022
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9419441/
https://www.ncbi.nlm.nih.gov/pubmed/38013970
http://dx.doi.org/10.1016/j.clicom.2022.08.003
_version_ 1784777176358322176
author Lombardi, Andrea
Azzarà, Cecilia
Renisi, Giulia
Viero, Giulia
Gori, Andrea
Bandera, Alessandra
author_facet Lombardi, Andrea
Azzarà, Cecilia
Renisi, Giulia
Viero, Giulia
Gori, Andrea
Bandera, Alessandra
author_sort Lombardi, Andrea
collection PubMed
description Passive immunization with mAbs has been employed in COVID-19. We performed a systematic review of the literature assessing the endogenous humoral immune response against SARS-CoV-2 in patients treated with mAbs. Administration of mAbs in seronegative patients led to a reduction in both antibody titres and neutralizing activity against the virus.
format Online
Article
Text
id pubmed-9419441
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The Authors. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-94194412022-08-30 Endogenous antibody response to SARS-CoV-2 in patients who received monoclonal antibodies against COVID-19: A systematic review Lombardi, Andrea Azzarà, Cecilia Renisi, Giulia Viero, Giulia Gori, Andrea Bandera, Alessandra Clinical Immunology Communications Short Communication Passive immunization with mAbs has been employed in COVID-19. We performed a systematic review of the literature assessing the endogenous humoral immune response against SARS-CoV-2 in patients treated with mAbs. Administration of mAbs in seronegative patients led to a reduction in both antibody titres and neutralizing activity against the virus. The Authors. Published by Elsevier Inc. 2022-12 2022-08-27 /pmc/articles/PMC9419441/ /pubmed/38013970 http://dx.doi.org/10.1016/j.clicom.2022.08.003 Text en © 2022 The Authors. Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Short Communication
Lombardi, Andrea
Azzarà, Cecilia
Renisi, Giulia
Viero, Giulia
Gori, Andrea
Bandera, Alessandra
Endogenous antibody response to SARS-CoV-2 in patients who received monoclonal antibodies against COVID-19: A systematic review
title Endogenous antibody response to SARS-CoV-2 in patients who received monoclonal antibodies against COVID-19: A systematic review
title_full Endogenous antibody response to SARS-CoV-2 in patients who received monoclonal antibodies against COVID-19: A systematic review
title_fullStr Endogenous antibody response to SARS-CoV-2 in patients who received monoclonal antibodies against COVID-19: A systematic review
title_full_unstemmed Endogenous antibody response to SARS-CoV-2 in patients who received monoclonal antibodies against COVID-19: A systematic review
title_short Endogenous antibody response to SARS-CoV-2 in patients who received monoclonal antibodies against COVID-19: A systematic review
title_sort endogenous antibody response to sars-cov-2 in patients who received monoclonal antibodies against covid-19: a systematic review
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9419441/
https://www.ncbi.nlm.nih.gov/pubmed/38013970
http://dx.doi.org/10.1016/j.clicom.2022.08.003
work_keys_str_mv AT lombardiandrea endogenousantibodyresponsetosarscov2inpatientswhoreceivedmonoclonalantibodiesagainstcovid19asystematicreview
AT azzaracecilia endogenousantibodyresponsetosarscov2inpatientswhoreceivedmonoclonalantibodiesagainstcovid19asystematicreview
AT renisigiulia endogenousantibodyresponsetosarscov2inpatientswhoreceivedmonoclonalantibodiesagainstcovid19asystematicreview
AT vierogiulia endogenousantibodyresponsetosarscov2inpatientswhoreceivedmonoclonalantibodiesagainstcovid19asystematicreview
AT goriandrea endogenousantibodyresponsetosarscov2inpatientswhoreceivedmonoclonalantibodiesagainstcovid19asystematicreview
AT banderaalessandra endogenousantibodyresponsetosarscov2inpatientswhoreceivedmonoclonalantibodiesagainstcovid19asystematicreview

Ejemplares similares